Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Naurex Raises $80 Million in Series C Financing to Advance Novel NMDA Receptor Modulators in Depression and Other CNS Di
EVANSTON, IL, December 3, 2014 - Naurex Inc., a biopharmaceutical company leveraging its unique platform to develop novel drugs for... Read more
Invitae Completes $120 Million Series F Financing
SAN FRANCISCO, October 13, 2014 - Invitae Corporation, a genetic information company, today announced the completion of a $120 million... Read more